A Multi-Center, Double-Masked Evaluation of the Efficacy and Safety of CSF-1 in the Treatment of Presbyopia

NCT03885011 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

166

Enrollment

INDUSTRY

Sponsor class

Conditions

Presbyopia

Interventions

DRUG: CSF-1
DRUG: CSF-1 Component #1
DRUG: CSF-1 Component #2

Sponsor

Orasis Pharmaceuticals Ltd.